Author:
Karachunsky A. I.,Rumyantseva Yu. V.,Lagoiko S. N.,Bührer C.,Tallen G.,Aleinikova O. V.,Bydanov O. I.,Korepanova N. V.,Baidun L. V.,Nasedkina T. V.,Stackelberg A. Von,Novichkova G. A.,Maschan A. A.,Litvinov D. V.,Ponomareva N. I.,Kondratchik K. L.,Mansurova E. G.,Fechina L. G.,Streneva O. V.,Yudina N. B.,Sharapova G. R.,Shamardina A. V.,Gerbek I. E.,Shapochnik A. P.,Rumyantsev A. G.,Henze G.
Publisher
LLC Obyedinennaya Redaktsiya
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,History,Family Practice
Reference31 articles.
1. Karachunskiy A, Herold R, von Stackelberg A, Miakova N, Timakow A, Mahortih T, Bajdun L, Maschan A, Fechina L, Shamardina A, Dudkin S, Lebedev V, Varfolomeeva S, Timofeeva V, Roumiantseva J, Chipsanova N, Rumjanzew A, Henze G: Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia. Leukemia. 2008;22: 1144-1153.
2. Labar B, Suciu S, Willemze R, Muus P, Marie JP, Fillet G, Berneman Z, Jaksic B, Feremans W, Bron D, Sinnige H, Mistrik M, Vreugdenhil G, De Bock R, Nemet D, Gilotay C, Amadori S, de Witte T; EORTC Leukemia Group: Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group. Haematologica. 2010;95:1489-1495.
3. Toft N, Birgens H, Abrahamsson J, Bernell P, Griškevičius L, Hallböök H, Heyman M, Holm MS, Hulegårdh E, Klausen TW, Marquart HV, Jónsson OG, Nielsen OJ, Quist-Paulsen P, Taskinen M, Vaitkeviciene G, Vettenranta K, Åsberg A, Schmiegelow K: Risk group assignment differs for children and adults 1—45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol. Eur J Haematol. 2013;90:404-412.
4. Cantrill HL, Waltman SR, Palmberg PF, Zink HA, Becker B. In vitro determination of relative corticosteroid potency. J Clin Endocrinol Metab. 1975;40:1073-1077.
5. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van’t Veer MB. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995;9: 1783-1786.